secwatch.observer — SEC 8-K summary
======================================

Issuer:     Indivior Pharmaceuticals, Inc. (INDV)
CIK:        0001625297
Form:       8-K
Filed at:   2025-03-27T23:59:59+00:00
Accession:  0001625297-25-000025
Event type: leadership
Sentiment:  positive
Materiality: 0.75
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Indivisor names Joe Ciaffoni CEO; proposes incentive plan with share price targets up to $35
--------------------------------------------------------------------------------

- Joe Ciaffoni to become CEO effective upon shareholder approval of new Directors' Remuneration Policy at May 8, 2025 AGM.
- On-hire PSU award up to 1.575M shares vests based on VWAP targets: $15, $20, $25, $30, $35 over 1–5 years.
- On-hire RSU award of 525,000 shares with cliff vest on 3rd anniversary of start date.
- Proposed policy increases LTIP on-target grant to 400% of salary in 2026 and 700% in 2027.
- Benchmarked vs US biopharma peers; CEO's potential dilution <2% of value created for shareholders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1625297/000162529725000025/0001625297-25-000025-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1625297/000162529725000025/indv-20250327.htm
  HTML page:      https://secwatch.observer/filing/0001625297-25-000025

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer